Apellis Pharmaceuticals Inc
Statements
Cash Flow
Apellis Pharmaceuticals Inc (APLS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -61 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.5 | -6.5 | -6.5 | -8.4 | -11 | -11 | -16 | -23 | -31 | -33 | -44 | -36 | -40 | -54 | -82 | -108 | -94 | -100 | 142 | -153 | -129 | -169 | -112 | -112 | -107 | -154 | -141 | -178 | -150 | -169 | -98 | -133 | -8.3 | 34 | 19 | -53 | 4.4 | 108 | -14 | -61 | 38 | |
| – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.1 | 0.1 | -0.2 | 0.1 | 0.1 | 0.1 | -0.1 | 0.1 | 0.1 | 0.3 | 0.3 | 0.4 | 0.8 | 0.3 | 0.4 | 0.4 | 0.3 | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | 0.3 | -1.2 | 0.3 | -0.2 | |
| 0.4 | 0.0 | 0.3 | 0.3 | 0.4 | 0.5 | 4.2 | 1.6 | 2.2 | 2.1 | 1.8 | 4.6 | 4.2 | 5.3 | 7.1 | 9.3 | 11 | 12 | 12 | 16 | 18 | 17 | 19 | 21 | 23 | 24 | 24 | 29 | 29 | 22 | 26 | 30 | 30 | 27 | 26 | 27 | 27 | 28 | -83 | 25 | -2.2 | |
| – | – | 1.1 | 0.3 | 0.4 | 0.5 | 5.6 | 1.8 | 2.4 | 2.1 | 1.3 | 6.5 | 13 | 5.9 | 12 | 78 | 8.7 | 9.4 | 53 | 75 | 39 | 85 | 76 | 22 | 36 | 65 | 29 | 35 | 36 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.4 | 0.7 | -0.2 | 0.3 | 0.2 | -0.1 | -1.6 | -3.0 | 0.3 | 0.2 | -9.5 | 8.3 | 18 | 10.0 | 17 | -19 | 12 | 21 | 5.8 | -45 | 50 | -58 | -41 | -1.8 | 19 | -21 | -4.4 | -36 | -64 | -57 | -43 | -103 | -6.2 | 63 | 28 | 10 | 18 | -136 | 23 | -106 | -201 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 | 0.9 | 0.9 | 0.9 | 0.2 | 0.5 | 0.2 | 0.4 | 0.5 | 3.7 | 0.7 | 0.5 | 0.2 | 0.4 | 0.0 | 0.1 | 0.4 | 0.2 | 0.9 | 0.3 | 0.4 | 0.0 | 0.1 | 0.3 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.0 | 0.4 | |
| – | – | – | – | – | – | – | – | -0.9 | -0.9 | -0.9 | -0.9 | -0.2 | -0.5 | -0.2 | -228 | -288 | 199 | -0.1 | -147 | 130 | 180 | 85 | -272 | 83 | 125 | 124 | -0.3 | -0.4 | 0.0 | 0.0 | -0.3 | -0.1 | – | 0.0 | 0.0 | 0.0 | -0.1 | -0.1 | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 17 | – | 1.6 | – | 1.6 | – | – | – | – | – | – | – | – | – | – | |
| – | – | 151 | 0.2 | 0.2 | 0.2 | 151 | 0.2 | 132 | 0.0 | 132 | 110 | 112 | 113 | 113 | 383 | – | – | 1.6 | -1.0 | -0.2 | -0.4 | -0.2 | – | -0.5 | -1.0 | 4.2 | -11 | 0.0 | 0.0 | 0.0 | 0.0 | – | 3.2 | – | – | 2.2 | – | -2.2 | – | – | |
| – | – | 26 | 26 | 26 | 26 | 26 | – | -22 | -22 | -22 | -22 | 206 | 206 | -0.5 | 323 | 323 | -0.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | – | – | 0.0 | 0.0 | – | – | |
| 7.4 | – | 15 | 19 | 19 | 19 | 178 | 0.2 | 132 | 0.0 | 0.1 | 148 | 41 | 199 | 0.2 | 403 | 282 | 0.9 | 6.3 | 1.6 | 4.5 | 2.1 | 384 | 377 | -4.7 | 9.6 | -16 | 391 | 1.6 | 5.7 | -3.9 | 108 | 42 | 2.5 | -4.0 | 0.3 | 6.6 | 0.8 | 1.3 | 0.1 | 8.7 | |
| 1.0 | -6.5 | -6.5 | -8.4 | -11 | 8.2 | 163 | -23 | 101 | -33 | -44 | 112 | 0.9 | 145 | -82 | 67 | -100 | 98 | 150 | -300 | 5.3 | 13 | 356 | -6.7 | -29 | -20 | -32 | 213 | -149 | -164 | -101 | -25 | 34 | 37 | 14 | -53 | 12 | 109 | -13 | -61 | 47 | |
| -6.5 | -6.5 | -6.5 | -8.4 | -11 | -11 | -16 | -23 | -31 | -33 | -44 | -36 | -40 | -54 | -82 | -109 | -95 | -104 | 141 | -154 | -129 | -169 | -113 | -112 | -107 | -155 | -142 | -178 | -151 | -169 | -98 | -133 | -8.4 | 34 | 19 | -53 | 4.4 | 108 | -14 | -61 | 38 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.